# The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients

> **NCT06428422** · NA · RECRUITING · sponsor: **Necmettin Erbakan University** · enrollment: 100 (estimated)

## Conditions studied

- Metastatic Non-small Cell Lung Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Bifidobacterium animalis subsp. lactis Bl-04
- **OTHER:** Plasebo

## Key facts

- **NCT ID:** NCT06428422
- **Lead sponsor:** Necmettin Erbakan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-12
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-12-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06428422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06428422, "The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06428422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*